CYP17A1 and in situ carcinoma: This finding is attributed to the blocking effect of CIS with the luteinizing hormone (LH) receptor, in addition to the downregulation of cytochrome P450 activity and the expression of steroidogenesis genes, including CYP19A1 and CYP17A1 [60,61,62].